Skip to main content
Skip to "About this site"
Canada.ca
Services
Departments
Language selection
Français
Search and menus
Search and menus
Patented Medicine Prices Review Board
Search
Search website
Search
[ENGLISH_LABEL_SITEMENU]
Legislation
Act and Regulations
Compendium of Policies, Guidelines and Procedures
Rules of Practice and Procedures for Hearings
Regulatory Management
Regulating Prices
Regulatory Process
Scientific Review
Price Review
New Patented Medicines Reported to PMPRB
Investigations
Advance Ruling Certificates
VCUs
Hearings
The Hearing Process
Status of Ongoing Proceedings
Decisions and Orders
Rules of Practice and Procedures for Hearings
Reporting
Reports and Trends
Pharmaceutical Trends
Annual Reports
NPDUIS
About NPDUIS
Analytical Studies
Research Agenda
NPDUIS Advisory Committee
You are here:
Home
Reports on New Patented Drugs for Human Use
Reports on New Patented Drugs for Human Use
Alphabetical list
A
- Reports on New Patented Drugs for Human Use starting with the letter A
B
- Reports on New Patented Drugs for Human Use starting with the letter B
C
- Reports on New Patented Drugs for Human Use starting with the letter C
D
- Reports on New Patented Drugs for Human Use starting with the letter D
E
- Reports on New Patented Drugs for Human Use starting with the letter E
F
- Reports on New Patented Drugs for Human Use starting with the letter F
G
- Reports on New Patented Drugs for Human Use starting with the letter G
H
- Reports on New Patented Drugs for Human Use starting with the letter H
I
- Reports on New Patented Drugs for Human Use starting with the letter I
J
- Reports on New Patented Drugs for Human Use starting with the letter J
K
- Reports on New Patented Drugs for Human Use starting with the letter K
L
- Reports on New Patented Drugs for Human Use starting with the letter L
M
- Reports on New Patented Drugs for Human Use starting with the letter M
N
- Reports on New Patented Drugs for Human Use starting with the letter N
O
- Reports on New Patented Drugs for Human Use starting with the letter O
P
- Reports on New Patented Drugs for Human Use starting with the letter P
Q
- Reports on New Patented Drugs for Human Use starting with the letter Q
R
- Reports on New Patented Drugs for Human Use starting with the letter R
S
- Reports on New Patented Drugs for Human Use starting with the letter S
T
- Reports on New Patented Drugs for Human Use starting with the letter T
U
- Reports on New Patented Drugs for Human Use starting with the letter U
V
- Reports on New Patented Drugs for Human Use starting with the letter V
W
- Reports on New Patented Drugs for Human Use starting with the letter W
X
- Reports on New Patented Drugs for Human Use starting with the letter X
Y
- Reports on New Patented Drugs for Human Use starting with the letter Y
Z
- Reports on New Patented Drugs for Human Use starting with the letter Z
A
Abreva
(
PDF
)
Aerius (
including Ref
)
Agenerase (
including Ref
)
Alertec
(
PDF
) (
Ref
)
Alimta
(
PDF
)
Alphagan (
including Ref
)
Alvesco
(
PDF
)
Amevive (
including Ref
)
Angiomax
(
including Ref
)
Aptivus
(Boehringer Ingelheim (Canada) Ltd.) (
PDF
)
Aranesp
(
Ref
)
Arixtra (
including Ref
)
Avastin (
including Ref
)
Avodart (
including Ref
)
Axert (
including Ref
)
Azilect
(
PDF
)
B
Baraclude
(Bristol-Myers Squibb Canada Inc.) (
PDF
)
BLES (
including Ref
)
Bondronat
(
PDF
) (
Ref
)
C
Celsentri
(
PDF
)
Cialis
(
PDF
)
Cancidas (
including Ref
)
Cerezyme
(
PDF
)
Cetrotide (
including Ref
)
Champix
(
PDF
)
Cipralex (
including Ref
)
Crestor
(
PDF
) (
Ref
)
D
E
Ebixa (
including Ref
)
Elidel
(
including Ref
)
Emend
(
PDF
)
Enablex
(
PDF
)
Erbitux
(
including Ref
)
Ezetrol (
including Ref
)
F
Fasturtec (
including Ref
)
Fuzeon
(
PDF
)
G
Gadovist (
including Ref
)
Gardasil
(Merck Frosst Canada Ltd.) (
PDF
)
Gleevec
(
PDF
) (
Ref
)
Gynazole-1 (
including Ref
)
H
Hectorol (
including Ref
)
Hepsera
(
PDF
)
Humira (
including Ref
)
I
Infergen (
including Ref
)
Integrilin (
including Ref
)
Invanz
(
PDF
)
Iressa
(
including Ref
)
Isentress
(
PDF
)
J
K
Keppra
(
PDF
)
Ketek
(
PDF
)
Kineret (
including Ref
)
L
Lantus (
including Ref
)
Levitra
(
including Ref
)
Lucentis
(
PDF
) (
Ref
)
Lyrica
(
PDF
)
M
MAbCampath
(
PDF
) (
Ref
)
Macugen
(
PDF
)
MultiHance (
including Ref
)
Myozyme
(
PDF
) (
Ref
)
N
Nevanac
(
PDF
) (
references
)
NovoRapid
(
PDF
)
O
Olmetec
(
PDF
)
Olmetec Plus
(
PDF
)
Orencia
(
PDF
)
Orgalutran (
including Ref
)
P
Pariet
(
PDF
) (
Ref
)
Pegasys (
including Ref
)
Pradax
(
PDF
) (
references
)
Prevnar
(
PDF
)
Prezista
(Janssen-Ortho Inc.) (
PDF
)
Pristiq
(
PDF
)
Pulmozyme
(
PDF
) (
Ref
)
Q
R
Relistor
(
PDF
) (
Ref
)
Relpax (
Ref
)
Remodulin
(
including Ref
)
Replagal
(
PDF
)
Revlimid
(
PDF
) (
Ref
)
Reyataz
(
PDF
)
RotaTeq
(
PDF
)
S
Sativex
(
PDF
)
Sensipar (
including Ref
)
Solagé (
PDF
)
Somavert
(
PDF
)
Spiriva
(
PDF
) (
Ref
)
Spriafil
(
PDF
)
Sprycel
(
PDF
) (
references
)
Sustiva
(
PDF
)
Sutent
(Pfizer Canada Inc.) (
PDF
)
T
Tarceva
(
PDF
)
Telzir (
Ref
)
TNKase
(
PDF
)
Torisel
(
PDF
)
Tracleer
(
PDF
) (
Ref
)
Tramacet
Travatan
(
PDF
) (
Ref
)
Trelstar
(
PDF
)
Trelstar LA
(
PDF
)
Tysabri
(
PDF
)
U
V
Vasovist
(
PDF
)
Valcyte (
including Ref
)
Vantas
(Paladin Labs Inc.) (
PDF
)
Vesicare
(
PDF
)
Vfend
(
PDF
)
Viread (
including Ref
)
W
X
Xatral
(
PDF
)
Xigris
(
PDF
) (
Ref
)
Xolair (
including Ref
)
Y
Yasmin (
including Ref
)
Z
Zavesca (
including Ref
)
Zelnorm
(
PDF
)
Zenapax (
including Ref
)
Ziagen
(
PDF
)
Date modified:
2016-11-14
Secondary menu